<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>RATIONALE: Hyperamylinemia is common in patients with <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, coincides with <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo>, and results in <z:mpath ids='MPATH_34'>amyloid deposition</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Amylin amyloids are generally considered a <z:e sem="disease" ids="C0030286" disease_type="Disease or Syndrome" abbrv="">pancreatic disorder</z:e> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>However, elevated circulating levels of amylin may also lead to amylin accumulation and proteotoxicity in peripheral organs, including the heart </plain></SENT>
<SENT sid="3" pm="."><plain>OBJECTIVE: To test whether amylin accumulates in the heart of <z:mp ids='MP_0001261'>obese</z:mp> and type 2 diabetic patients and to uncover the effects of amylin accumulation on cardiac <z:mp ids='MP_0000002'>morphology</z:mp> and function </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS AND RESULTS: We compared amylin deposition in failing and nonfailing hearts from lean, <z:mp ids='MP_0001261'>obese</z:mp>, and type 2 diabetic humans using immunohistochemistry and Western blots </plain></SENT>
<SENT sid="5" pm="."><plain>We found significant accumulation of large amylin oligomers, fibrils, and plaques in failing hearts from <z:mp ids='MP_0001261'>obese</z:mp> and diabetic patients but not in <z:mpath ids='MPATH_458'>normal</z:mpath> hearts and failing hearts from lean, nondiabetic humans </plain></SENT>
<SENT sid="6" pm="."><plain>Small amylin oligomers were even elevated in nonfailing hearts from overweight/<z:mp ids='MP_0001261'>obese</z:mp> patients, suggesting an early state of accumulation </plain></SENT>
<SENT sid="7" pm="."><plain>Using a rat model of hyperamylinemia transgenic for human amylin, we observed that amylin oligomers attach to the sarcolemma, leading to myocyte Ca(2+) dysregulation, pathological myocyte remodeling, and diastolic dysfunction, starting from <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e> rats expressing the same level of <z:mp ids='MP_0002169'>wild-type</z:mp> rat amylin, a nonamyloidogenic isoform, exhibited <z:mpath ids='MPATH_458'>normal</z:mpath> heart structure and function </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Hyperamylinemia promotes amylin deposition in the heart, causing alterations of cardiac myocyte structure and function </plain></SENT>
<SENT sid="10" pm="."><plain>We propose that detection and disruption of cardiac amylin buildup may be both a predictor of heart dysfunction and a novel therapeutic strategy in diabetic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
</text></document>